X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG DELIVERY

期刊標題檢索 DRUG DELIV 最新評論: Submitted in May 25th, 25 years ago, with a bunch of ethical require... (2026-01-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG DELIVERY]您好,您是該頁面的第 184324 位訪客。

期刊簡介
期刊名稱DRUG DELIVERY DRUG DELIVERY
LetPub Score
6.9
50 ratings
Rate

Reputation
7.7

Influence
6.2

Speed
8.4

期刊簡稱DRUG DELIV
ISSN1071-7544
E-ISSN1521-0464
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
16.401.3801.265
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q17 / 185

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.
官方網站http://informahealthcare.com/drd
在線稿件提交https://mc.manuscriptcentral.com/udrd
開放訪問Yes
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1993
每年文章數40每年文章數趨勢
黃金OA百分比99.53%
OA Related Info
APC: Yes( EUR2875; USD2990; GBP2392; )
APC waiver:Check Notes
Other charges: No
Keywords: drug delivery systems、drug targeting、pharmaceutical sciences
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ117/352
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1071-7544%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【DRUG DELIVERY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.00
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 23.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 36.00
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 25.70
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 26.20
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.50
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.60
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 14.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 12.80
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 14.40
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23306516
    BIOMEDICINE & PHARMACOTHERAPY514391
    PHYTOMEDICINE474407
    LIFE SCIENCES414692
    European Journal of Pharmacology345318
    PHARMACOLOGICAL RESEARCH307374
    International Journal of Pharmaceutics277231
    BIOCHEMICAL PHARMACOLOGY275184
    JOURNAL OF NATURAL PRODUCTS204477
    BRITISH JOURNAL OF PHARMACOLOGY182289
  •  

    DRUG DELIVERY DRUG DELIVERY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [DRUG DELIVERY] 的評論撰寫評論
作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-12-18 20:21:49 評論於
Do you charge a layout fee?
(0) 讚! | 凌霄高洁

作者: 西风念云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-04-27 19:20:52 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0
Sharing experience: This journal is relatively easy, with an Impact Factor of over 2. The review process takes a little over a month. When submitting, you can recommend your own reviewers, as the editors of this journal prefer to have the manuscripts reviewed by reviewers recommended by the authors themselves. This is more beneficial for the acceptance of the articles
(0) 讚! | 西风念云

作者: smallbird119


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2014-04-02 14:16:36 評論於
has a history of submission speed and the fastest receiving journalMy review started to select for a lot of journals, because it’s not a draft, so it’s been a long time.After summing up the experience, I decided to select drug delivery, because the content I wrote should be in line with the requirements of the journal. So the receiving speed is very fast. I also like this journal. I believe it will be able to climb.Therefore, I feel that I should be optimistic about submiting in articles. I can’t blindly select for it.
(1) 讚! | smallbird119

作者: 金蛇盼山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-04-02 10:18:50 評論於
Review Speed: 1.0 Experience Sharing: The fastest journal ever in terms of submitting and accepting my submission. I have submitted my review to many journals in the past, but since they were not solicited, it took a long time to get accepted. After summarizing my experience, I decided to submit to Drug Delivery as the content I wrote should align well with the requirements of the journal. The acceptance speed was very fast, and I am very impressed with this journal. I believe it will continue to rise, so I think being selective in where to submit articles is important, rather than blindly submitting
(0) 讚! | 金蛇盼山

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-11-08 13:41:00 評論於
Magazine is very good and veryfast.In the beginning of September, he selectd in the past, and after two weeks, he returned to the manuscript. The reviewer’s opinion was very pertinent. After the change, he was returned two days later and the notice was accepted.Very fast, the opinions are fair, the better journals, I believe the impact factor will climb all the way.
(0) 讚! | 匿名

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-10-31 08:20:00 評論於
From submission to receiving less than two months, the speed is very fast, after the review is first overhaul, then minor repair, it is received.The impact factor has also risen from 1.5 to 2.0. The editor-in-chief is a big drug, and I believe that the impact factor of this journal will continue to climb.
(0) 讚! | 匿名

作者: 伟诚可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-08 11:20:11 評論於
Review speed: 1.0 | Acceptance rate: 75.0
Sharing experience: It was my first time submitting to this journal. After two days of submission, it was under review. I received reviewers' comments after 29 days. There were two reviewers. I made minor revisions and it was accepted the next day. I really feel that the editors of this journal are very efficient. Hopefully, the Impact Factor will increase, and this journal has a promising future! Wishing everyone smooth submissions!
(0) 讚! | 伟诚可爱吗

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-10-08 11:08:00 評論於
The first time to select for this journal, 29 days after the select for review comments, very simple questions.After revise, receive it directly one day.The whole process is very fast, it is very shocking~ The journal editor is very efficient, I hope to continue, and I hope the influence factor is getting higher and higher!I wish everyone a smooth submission!
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 22:35:25 評論於
We have crossed the two-point mark. Will we continue to make progress next year? There is a lot of hope
(0) 讚! | 凌霄高洁

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-06-21 14:44:00 評論於
is quite slow, it has been five months, and it is still in preliminary review.
(0) 讚! | 匿名

作者: 如冬公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-06-21 14:03:17 評論於
Review speed: 1.0 | Submission hit rate: 5.0
Experience sharing: Quite slow, it has been five months and the initial review is still ongoing
(0) 讚! | 如冬公子

作者: 太虚康震


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-18 09:56:52 評論於
This magazine is so bad. I have been waiting for over 3 months for my submission to be reviewed and it is still under review. What's even more frustrating is that I have sent multiple reminder emails, but the editor completely ignores them. This magazine lacks integrity. My colleague submitted an article in August, it was scheduled for revisions in November, and finally published in January. However, the publication falsely stated that the submission was received in November. I only realized this after submitting another article to the same magazine. I suggest that everyone avoid submitting to this publication
(0) 讚! | 太虚康震

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-04-18 09:08:00 評論於
I wanted Drug Delivery to be a decent journal, but I don’t think that’s the case. I submitted my paper more than 3 months ago and it is still under review. I’ve emailed the editor a few times and they have never responded. Perhaps I should have known as a tech in my lab submitted their manuscript last August, and received reviews in November. The only reason I submitted is because the time to publication after your article has been accepted is quick. Based on my experience, I don’t recommend submitting to this publication.

(0) 讚! | 匿名

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-11-24 20:13:00 評論於
Can you give an online submission URL?What?
(0) 讚! | 匿名

作者: 宛旋小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-11-24 13:29:28 評論於
Could you please provide a link to submit online?
(0) 讚! | 宛旋小可爱

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-19 21:28:00 評論於
Journal Homepage URL: http://informahealthcare.com/drd
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-05-27 09:49:45 評論於
My major revision has been submitted for a month, but it is still awaiting process. It's urgent
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-04-07 11:27:37 評論於
Review speed: 2.0 Experience sharing: After submitting the manuscript, it entered "under review" in about a week. The review comments came back after 2 months for major revisions, but the issues were relatively simple. The revision deadline was 1 month, I uploaded the revised manuscript in 20 days, and the status remained unchanged from "awaiting processing" throughout. However, it showed "accepted" directly after 2 weeks. The entire process took 3 months, which is still considered relatively fast
(0) 讚! | 凌霄高洁

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-03-29 18:07:00 評論於
After half a month, I haven't seen under review
(0) 讚! | 匿名

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2010-08-12 21:29:00 評論於
Bimonthly, I think it may be very slow when I selectd, but I quickly returned to the opinion. The editor also apologized and said that the reply was late.It is easier to feel that drug targeting is easier.
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-06-17 16:24:38 評論於
It took 5 weeks from being in awaiting office processing to under review. It has been under review for 10 days now
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-06-11 11:36:00 評論於
After 17 days of submission, the status has changed from "awaiting office processing" to "under review". Currently in waiting
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-06-05 12:32:03 評論於
Excuse me, what is the homepage for drug delivery?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-05-19 16:44:42 評論於
I have been waiting for a month and still have not received any updates. It has been stuck in the "awaiting process" status
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-02-23 17:26:01 評論於
This magazine processes submissions pretty quickly, usually accepting minor revisions in about a month and a half. Submissions are done entirely through email. The editor apologizes frequently for any delays, acknowledging that they have made authors wait too long
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [DRUG DELIVERY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*